• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE SCAFFOLD Back to Search Results
Catalog Number UNK ABSORB
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Death (1802)
Event Date 11/01/2016
Event Type  Death  
Manufacturer Narrative
Exemption number (b)(4).The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the u.S.Product performance engineering reviewed the incident information; however, there was no reported device malfunction and the product was not returned.A review of the lot history record and complaint history could not be conducted because the part and lot number were not provided.The reported patient effects of death, is listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use (ifu) as a known adverse event associated with the use of a coronary scaffold in native coronary arteries.Based on the case information, a conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.(b)(4).
 
Event Description
It was reported through a research article that absorb bioresorbable vascular scaffolds may be related to death.Specific patient information is documented as unknown.Details are listed in the article titled: two-year clinical outcomes of the ¿italian diffuse/multivessel disease absorb prospective registry¿ (it-disappears).
 
Manufacturer Narrative
Date of death, event and implant: are estimated dates.In the absence of reported part number, unique device identifier (udi) cannot be calculated.Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the u.S.Product performance engineering reviewed the incident information; however, there was no reported device malfunction and the product was not returned.A review of the lot history record and complaint history could not be conducted because the part and lot number were not provided.The reported patient effects of death, is listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use (ifu) as a known adverse event associated wit the use of a coronary scaffold in native coronary arteries.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.(b)(4).
 
Event Description
It was reported through a research article that absorb bioresorbable vascular scaffolds may be related to death.Specific patient information is documented as unknown.Details are listed in the attached article titled: two-year clinical outcomes of the ¿(b)(4) diffuse/multivessel disease absorb prospective registry¿ (it-disappears).
 
Manufacturer Narrative
This report is resubmitted to ensure the enclosed attachment can be easily opened by the fda.Attachment: literature attachment "two- year clinical outcomes of the italian diffuse/multivessel disease absorb prospective registry (it-dissapears).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE SCAFFOLD
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key8828117
MDR Text Key152246742
Report Number2024168-2019-10375
Device Sequence Number1
Product Code PNY
Combination Product (y/n)Y
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup,Followup
Report Date 07/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK ABSORB
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/03/2019
Initial Date FDA Received07/25/2019
Supplement Dates Manufacturer Received07/25/2019
07/20/2020
Supplement Dates FDA Received08/02/2019
07/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age60 YR
-
-